In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Endovascular Embolization Before Stereotactic Radiosurgery for Brain Arteriovenous Malformations

    Final Number:
    1122

    Authors:
    John D. Nerva MD; Jason Barber MS; Louis J. Kim MD; Jason K. Rockhill MD, PhD; Danial K. Hallam MD, MSc; Basavaraj Ghodke MD; Laligam N. Sekhar MD, FACS

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2015 Annual Meeting

    Introduction: The effectiveness and safety of endovascular embolization of brain arteriovenous malformations (BAVMs) as adjunctive therapy for stereotactic radiosurgery (SRS) is controversial. The purpose of this study was to compare clinical and radiographic outcomes of patients treated without and with embolization prior to SRS.

    Methods: 106 consecutive patients treated with SRS were identified from a database of BAVMs treated from 2005-2012 at our institution and retrospectively reviewed. 35 patients were excluded from analysis for treatment before 2005, treatment at outside institutions, or lack of follow-up. Embolization was performed with Onyx®, and SRS was performed using Gamma Knife®. The modified Rankin scale (mRS) was use to assess pre-SRS and post-SRS functional status.

    Results: 20/71 patients (39%) underwent BAVM embolization prior to SRS. Embolization was used more frequently for ruptured compared to unruptured BAVMs (65% vs 31%, p = .015). There were no significant differences in age, Spetzler-Martin grade, modified Pollock-Flickinger score, or location between embolization and non-embolization patients although embolization patients were on average younger (32 vs 39 years, p = .187) and had higher grade BAVMs (3.3 vs 2.8, p = .128). Mean follow-up (3.7 vs 3.7 years, p = .961) and mean mRS change with SRS (0.05 vs -0.06, p = .722) were similar between embolization and non-embolization patients. Kaplan-Meier survival analysis found no significant differences in rates of cure (50% vs 61%, HR 0.87, p = .715) or complication after SRS (25% vs 33%, HR 0.54 p = .286) between embolization and non-embolization patients. There was 1 neurological complication after embolization in 41 total treatments (2.4%).

    Conclusions: Embolization of BAVMs prior to SRS appears to be a safe treatment option. There were no significant differences in clinical and radiographic outcomes between embolization and non-embolization patients. In this series, embolization was used more frequently to treat ruptured BAVMs prior to SRS.

    Patient Care: In selected patients, endovascular embolization may be a safe adjunctive therapy prior to SRS for BAVMs. Embolization did not negatively impact outcomes in this series. Embolization was used more frequently for patients presenting with hemorrhage and in larger volume BAVMs, on average.

    Learning Objectives: 1) Describe the indications for and methods of endovascular embolization of BAVMs prior to stereotactic radiosurgery. 2) Discuss the clinical and radiographic outcomes of SRS for BAVMs without and with prior endovascular embolization. 3) Identify an effective treatment for patients with ruptured and unruptured BAVMs who are candidates for SRS.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy